	Clinician-led, single-blind, randomised controlled trial evaluating the efficacy of a high-intensity resistance and impact training intervention for improving health-related quality of life in people with multiple sclerosis: protocol for STRONG-MS. BMJ Open Sport Exerc Med Grech L, Beck B, Scott D, Sim M, Mesinovic J, Jansons P, Rodrigues Fonseca F, Abimanyi-Ochom J, Allan M, Blum S, Butler E, Carroll W, Caswell N, Ebeling P, Gan V, Herschtal A, John N, Kermode A, Le-Kavanagh L, Bohingamu Mudiyanselage S, Ohman LE, Poposka M, Reece A, Sansom P, Scroggie C, Todaro C, Watts J, Zengin A. PMID: 41736941
	PMID: 41733671
	Evaluation of a group compassion-based program for perceived social isolation and depression in family caregivers of patients with multiple sclerosis: study protocol for an open-label randomized controlled trial. Trials Nabi F, Yousefi H, Babaee S, Shaygannejad V. PMID: 41731538 [PubMed - as supplied by publisher]
	Latent, Lytic, and Linked to Multiple Sclerosis-How EBV Drives Autoimmunity. Eur J Immunol Läderach F, Bremer E, Münz C. PMID: 41723724 [PubMed - indexed for MEDLINE]
	Response to the letter to the editor regarding "Efficacy of caffeine supplementation on fatigue in patients with multiple sclerosis: A randomized double-blind placebo-controlled trial". Mult Scler Relat Disord Baghbanian SM, Gharanjik A, Ghazaeian M, Bakhshi A, Hosseinnataj A. PMID: 41722293 [PubMed - as supplied by publisher]
	Disability progression in multiple sclerosis: a latent class analysis of predictors. J Neurol Guo J, Olsson T, Alfredsson L, Hedström AK. PMID: 41721025 [PubMed - indexed for MEDLINE]
	Abuse in individuals with multiple sclerosis: the SocialMS Italian study. Mult Scler Relat Disord Ponzano M, Signori A, Schiavetti I, Landi D, Bellavia A, Lavorgna L, Fantozzi R, Buttari F, Di Sapio A, Malucchi S, Marinelli F, Battaglia MA, Vercellino M, Callari G, Frau J, Marfia GA, Tsantes E, Grasso MG, Surcinelli A, Zuliani L, Cordioli C, Sinisi L, Clerici R, Immovilli P, Stromillo ML, Mori L, Laroni A, Lanzillo R, Lugaresi A, Sormani MP, SocialMS study group. PMID: 41719899 [PubMed - as supplied by publisher]
	Outcome Predictors in Progressive Multifocal Leukoencephalopathy Associated With Multiple Sclerosis Treatments: A Multicenter Cohort Study. Neurol Neuroimmunol Neuroinflamm Blant JC, De Rossi N, Gold R, Maurousset A, Kraemer M, Romero-Pinel L, Misu T, Ouallet JC, Pallix Guyot M, Gerevini S, Bakirtzis C, Piñar Morales R, Vlad B, Karypidis P, Moisset X, Derfuss TJ, Jelcic I, Martin-Blondel G, Ayzenberg I, McGraw C, Laplaud DA, Lebrun-Frenay C, Du Pasquier RA, Bernard-Valnet R, CORPUS and Italian PML study groups. PMID: 41719500 [PubMed - indexed for MEDLINE]
	Tolebrutinib Phase 2b Long-Term Extension Study: Two-Year Safety, MRI, and Clinical Efficacy Outcomes in Patients With Relapsing Multiple Sclerosis Patients. Neurol Open Access Oh J, Fox RJ, Arnold DL, Syed S, Dukovic D, Vargas WS, Turner TJ, Underwood CF, Long TM, Traboulsee AL, Reich DS. PMID: 41717535 [PubMed]
	TMS-EEG signatures of motor network dysfunction in multiple sclerosis. Brain Commun Leodori G, Mancuso M, Maccarrone D, Tartaglia M, De Bartolo MI, Collura A, Pellegrini S, Malimpensa L, Belvisi D, Ferrazzano G, Ziemann U, Conte A. PMID: 41717136 [PubMed]
	Serum neurofilament light chain and disease-modifying treatment as predictors of cognitive decline in multiple sclerosis. Front Neurol Taluntiene V, Giedraitiene N, Kizlaitiene R, Vaisvilas M, Kaubrys G. PMID: 41716551 [PubMed]
	Association of Neurodevelopmental Disorders and Congenital Anomalies With Prenatal Multiple Sclerosis Treatment-Real-World Historical Cohort Study. Clin Pharmacol Ther Rosh B, Levi O, Stein N, Yahav A, Gronich N. PMID: 41715957 [PubMed - as supplied by publisher]
	Radiomics and Artificial Intelligence in Multiple Sclerosis MRI: A Comprehensive Review. AJNR Am J Neuroradiol Petrou K, Ploussi A, Seimenis I, Karavasilis E, Velonakis G, Efstathopoulos EP. PMID: 41714129 [PubMed - as supplied by publisher]
	A longitudinal study of depression, anxiety, and disability in multiple sclerosis: Profile and trajectories analyses. J Affect Disord Aloni R, Peretz O, Koren M. PMID: 41713613 [PubMed - as supplied by publisher]
	Using cognitive testing to predict employment status in multiple sclerosis: A comparative study of the SDMT and a computerized cognitive assessment tool. Mult Scler Relat Disord Jackson DA, Bergmann CS, Wilken J, Weller J, Zarif M, Bumstead B, Buhse M, Jo M, Barrera MA, Penner IK, Morrow SA, Hancock LM, Bogaardt H, Covey TJ, Doniger GM, Golan D, Gudesblatt M. PMID: 41713333 [PubMed - as supplied by publisher]
	Prevalence and factors associated with polypharmacy among people with multiple sclerosis (PwMS) receiving outpatient rehabilitation: A cross-sectional study. Mult Scler Relat Disord Feng G, Scandiffio J, Law V, Oh J, Bayley M, Simpson R. PMID: 41713332 [PubMed - as supplied by publisher]
	Editorial for "Association Between Intermittent Fasting and Susceptibility-Weighted MRI Phase Values in Deep Gray Matter of Patients With Multiple Sclerosis: An Observational Cohort Study". J Magn Reson Imaging So TY, Chen W. PMID: 41711593 [PubMed - as supplied by publisher]
	Impact of whole-body vibration training on gait in patients with progressive multiple sclerosis: a pilot randomised study. BMJ Neurol Open Konitsioti AM, Göreci Y, Hellmich M, Schweitzer F, Blaschke S, Golla H, Waßner L, Stolzenberger J, Fink GR, Schroeter M, Schoenau E, Stark C, Warnke C. PMID: 41710925 [PubMed]
	Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in China. BMC Neurol Tan H, Zhou L, Gao Y, Zhao C, Lu C, Dong Q, ZhangBao J, Quan C. PMID: 41709182 [PubMed - as supplied by publisher]
	Hepatic Safety of Adjunctive High-Dose Melatonin in Participants Receiving Ocrelizumab for Primary Progressive Multiple Sclerosis: Liver Toxicity Findings from a Phase I/II Randomised Clinical Trial (MELATOMS-1). CNS Drugs Bejarano I, Jiménez-Jorge S, Lobo-Acosta MÁ, Álvarez-López AI, Rosso-Fernández CM, López-Ruiz R, Eichau S, Ruiz-Peña JL, Géniz MÁ, Ampuero J, Ponce-España E, Merino-Bohorquez V, Cameán M, García-Sánchez MI, Izquierdo G, Guerrero JM, Romero-Gómez M, Lardone PJ, Carrillo-Vico A. PMID: 41706381 [PubMed - as supplied by publisher]

Articles 1 - 20 / 43380

Page 1 of 2169



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy